Optiver Holding’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-32,724
Closed -$1.41M 568
2023
Q3
$1.41M Sell
32,724
-8,488
-21% -$396K ﹤0.01% 387
2023
Q2
$1.97M Buy
41,212
+4,810
+13% +$232K ﹤0.01% 347
2023
Q1
$1.77M Sell
36,402
-157,019
-81% -$7.99M ﹤0.01% 356
2022
Q4
$10.3M Sell
193,421
-18,578
-9% -$916K 0.01% 236
2022
Q3
$9.48M Sell
211,999
-94
-0% -$4.64K 0.01% 186
2022
Q2
$10.5M Buy
212,093
+48,567
+30% +$2.37M 0.01% 156
2022
Q1
$8.54M Sell
163,526
-433,900
-73% -$22.4M 0.01% 146
2021
Q4
$33.7M Buy
597,426
+212,848
+55% +$12.2M 0.03% 112
2021
Q3
$21.2M Buy
384,578
+76,010
+25% +$4.23M 0.02% 108
2021
Q2
$15.8M Buy
+308,568
New +$15.9M 0.02% 96

Other funds holding QGEN

Optiver Holding's QGEN Position: Q1 2026 in Review

Optiver Holding sold out of Qiagen (QGEN) in Q1 2026, closing a stake of 3,452 shares — an estimated $155K sold.

Optiver Holding first reported a position in QGEN in Q1 2022 and held it in 4 quarters. The position peaked at $3.93M in Q1 2022. 343 funds tracked by Wall St. Rank hold QGEN as of Q1 2026.

  • Optiver Holding reported no remaining Qiagen position as of Q1 2026 after selling out during the quarter.
  • Optiver Holding sold 3,452 Qiagen shares in Q1 2026, an estimated $155K.
  • Optiver Holding first reported a position in Qiagen in Q1 2022 and held it in 4 quarters.
  • Optiver Holding's Qiagen position peaked at $3.93M in Q1 2022.
  • 343 funds tracked by Wall St. Rank held Qiagen as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.